At a low dosage of 2 × 106 CAR-T cells, both CAR-T cells exhibited better tumor-control capability (Fig. 4H) in HGC27-Gsh bearing mice without significant body weight change (Fig. 4I). The gene discussed is GSS; the disease is neoplasm.